UAE Contract Manufacturing Organizations Market to be dominated by Active Pharmaceutical Ingredient (API) Manufacturing till 2027


Enhancing focus on specialty medicines, expanding nuclear medicines sector, and technological advancements in cell and gene therapies drives the growth for UAE contract manufacturing organizations market in the forecast period, 2023-2027.

According to TechSci Research report, UAE Contract Manufacturing Organizations Market By Region, Competition Forecast & Opportunities, 2027, the UAE Contract Manufacturing Organizations market is expected to witness growth at a significant rate in 2023-2027. Contract manufacturing refers to an outsourcing process, where a manufacturer initiates a formal agreement with another manufacturing firm for its parts, products, and components. The initiator manufacturer utilizes these in its manufacturing process for manufacturing its products. A contract manufacturing organization (CMO) represents an organization that serves the pharmaceutical sector and offer clients with comprehensive services, from drug development to manufacturing. Outsourcing to a CMO enables the pharmaceutical clients to extend the technical resources without increased overhead.

The expanding pharmaceutical industry and the inflating need for state-of-the-art processes and production technologies proves to be effective in meeting regulatory requirements which propels the market growth. CMOs are consolidating as a means of improving profitability in the competitive market. Additionally, the increase in demand for generic medicines and biologics, the capital-intensive nature of the business, and the rigorous manufacturing requirements have encouraged pharmaceutical companies to identify the potential profitability in contracting with a CMO (contract manufacturing outsourcing) for clinical as well as commercial stage manufacturing.

However, the implementation of numerous strict regulations put limitations for contract manufacturing organizations to gain business deals and the need of CMOs to be approved by specific regulatory bodies may restricts the market growth in the upcoming years.


Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on “UAE Contract Manufacturing Organizations Market”

The UAE contract manufacturing organizations market is segmented into type, end user, regional distribution, and competitive landscape.

Based on type, the market is divided into active pharmaceutical ingredients (API) manufacturing, finished dosage formulation (FDF) development & manufacturing, and secondary packaging. Active pharmaceutical ingredients (API) manufacturing is expected to witness the significant market share in the forecast period, 2023-2027. The introduction of several government initiatives in the healthcare industry, product innovations in biologics, and an increase in the cases of cancer and age-related diseases are driving the market growth. The enhancing focus on the development of biological APIs, which is driving the API manufacturing segment of the market. The rising emphasis on high-potency APIs and the novel technologies for HPAPIs supports the growth of the market.

Based on end-user, the market is divided into big pharmaceuticals, small and mid-size pharmaceuticals, generic pharmaceutical companies, and others. Big pharmaceuticals are anticipated to account for a largest market share in the forecast period. This segment is dominating due to the rise in demand for end-to-end services in big pharmaceutical organizations and increasing pricing pressure and pipeline challenges in their operations. This further results into a shift towards contract development and manufacturing. The inflating need to streamline execution costs as a result of the patent expiry of blockbuster drugs are expected to promote the market growth in the forecast period.

Leading market players operating in the UAE Contract Manufacturing Organizations market are:

  • Life Pharma FZE
  • Pharmax Pharmaceuticals FZ-LLC
  • Julphar Pharmaceuticals
  • Vieco Pharmaceuticals FZCO
  • ADCAN Pharma
  • Neopharma Pharmaceuticals
  • Pharma Solutions

Download Sample Report

Customers can also request for 10% free customization on this report.

CMOs offer services at competitive pricing and focuses on streamlining the business relationships, drives the growth of the contract manufacturing organizations market. In addition to this, the escalating demand for generic drugs and the protection provided by CMO to patent expiration for several major drugs are accelerating the market growth.  With this, the growing pressure on minimizing healthcare expenditure by reducing the cost of pharmaceutical products is further fuelling the market growth. The elevating number of cell therapy candidates, along with the continuous progression through the several phases of clinical development and their complex manufacturing process, thereby increases the need for facilities that offer manufacturing services for these therapies. This, in turn, is projected to stimulate the UAE Contract Manufacturing Organizations market growth till 2027.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm”.

UAE Contract Manufacturing Organizations Market By Type (Active Pharmaceutical Ingredients (API) Manufacturing, Finished Dosage Formulation (FDF) Development & Manufacturing, Secondary Packaging), By End User (Big Pharmaceuticals, Small and Mid-Size Pharmaceuticals, Generic Pharmaceutical Companies, Others), By Region, Competition Forecast & Opportunities, 2027” has analyzed the future growth potential of UAE Contract Manufacturing Organizations  market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and assist decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with significant drivers, challenges, and opportunities in UAE Contract Manufacturing Organizations market.


Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]